Hydroxyethyl Starch for Fluid Replacement Therapy in High-Risk Surgical Patients: Context and Caution

JAMA. 2020 Jan 21;323(3):217-218. doi: 10.1001/jama.2019.20141.

Authors

Fernando G Zampieri^{1

2}, Alexandre B Cavalcanti¹

Affiliations

¹ Research Institute, HCor (Hospital do Coração), São Paulo, Brazil.
² Center for Epidemiological Research, University of Southern Denmark, Odense, Denmark.

PMID: 31961399
DOI: 10.1001/jama.2019.20141

No abstract available

Publication types

Editorial
Comment

MeSH terms

Abdomen
Fluid Therapy*
Humans
Hydroxyethyl Starch Derivatives*
Postoperative Complications

Substances

Hydroxyethyl Starch Derivatives